# Trial of Aspirin and Arginine Restriction in Colorectal Cancer

> **NCT00578721** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 24 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00578721
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-24
- **Primary completion:** 2013-11-26
- **Final completion:** 2013-11-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578721, "Trial of Aspirin and Arginine Restriction in Colorectal Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00578721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*